Pharmaceutical company Corcept and Teva lost patent dispute, stock price plummets
六月清晨搅
发表于 2023-12-30 10:17:06
266
0
0
In the patent infringement lawsuit filed by pharmaceutical company Corcept Therapeutics, a US judge ruled in favor of Israeli pharmaceutical company Teva Pharmaceutical Industries, causing Corcept's stock to be wildly sold off, causing its stock price to drop nearly 38% in trading.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- The stock price of Trump Media Technology Group rose by over 15% after the US stock market closed
- Suddenly changed! Big news from chip giants! Samsung Electronics' stock price rises
- The stock price of Supermicro Computer has surged by 40%! What happened?
- Novo Nordisk's stock price returns to its starting point at the beginning of the year! Falling sales of weight loss drugs scare off investors
- Su Zifeng was elected as the CEO of Time magazine of the year! AMD's stock price has risen by 3700% since taking office
- Strong demand for AI drives Broadcom's profits beyond expectations, causing its stock price to soar 15% after hours
- Top 20 US Stock Transactions: Adobe's Poor Performance, Stock Price Falls 13.7%
- Micron Technology's stock price plummeted by about 18% after the market closed
- Goldman Sachs: Lowering Micron Technology's Target Stock Price to $128
- Lilly's stock price surged 10% before the US stock market opened
